Continuing global improvement in Human Papillomavirus DNA genotyping services: The 2013 and 2014 HPV LabNet International Proficiency Studies
Persistent infection with high risk human papillomavirus (HPV) is the major risk factor for cervical cancer [1]. Twelve HPV types are classified as carcinogenic to humans by the International Agency for Research on Cancer (IARC) [2], of which HPV 16 is the most carcinogenic type [2]. Accurate and internationally comparable HPV DNA detection and genotyping methodology is essential both for HPV vaccine research and for effective implementation and monitoring of HPV vaccination programs.
Source: Journal of Clinical Virology - Category: Virology Authors: Carina Eklund, Ola Forslund, Keng-Ling Wallin, Joakim Dillner Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Cervical Cancer | Cervical Cancer Vaccine | Genital Warts | Human Papillomavirus (HPV) | Study | Vaccines | Virology